Dariush Shanehbandi
1,2, Jafar Majidi
1*, Tohid Kazemi
1,2*, Behzad Baradaran
1, Leili Aghebati-Maleki
1,2, Farzaneh Fathi
2,3, Jafar Ezzati Nazhad Dolatabadi
31 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Purpose: Surface plasmon resonance (SPR) sensing confers a
real-time assessment of molecular interactions between biomolecules and their
ligands. This approach is highly sensitive and reproducible and could be
employed to confirm the successful binding of drugs to cell surface targets.
The specific affinity of monoclonal antibodies (MAb) for their target
antigens is being utilized for development of immuno-sensors and therapeutic
agents. CD20 is a surface protein of B lymphocytes which has been widely
employed for immuno-targeting of B-cell related disorders. In the present
study, binding ability of an anti-CD20 MAb to surface antigens of intact target
cells was investigated by SPR technique.
Methods: Two distinct strategies were used for immobilization
of the anti-CD20 MAb onto gold (Au) chips. MUA (11-mercaptoundecanoic acid) and
Staphylococcus aureus protein A (SpA) were the two systems used for this
purpose. A suspension of CD20-positive Raji cells was injected in the analyte
phase and the resulting interactions were analyzed and compared to those of
MOLT-4 cell line as CD20-negative control.
Results: Efficient binding of anti-CD20 MAb to the surface
antigens of Raji cell line was confirmed by both immobilizing methods, whereas
this MAb had not a noticeable affinity to the MOLT-4 cells.
Conclusion: According to the outcomes,
the investigated MAb had
acceptable affinity and specificity to the target antigens on the cell surface
and could be utilized for immuno-detection of CD20-positive intact cells by SPR
method.